Company Details
Website
Location
- 3802 Spectrum Blvd, Tampa, FL 33612
Founding Date
- 2009
Non-Florida HQ
Company Description
- Cvergenx has developed a unique molecular diagnostic assay that identifies differences in tumor radiosensitivity, which allows the appropriate selection of patients most likely to benefit from radiation therapy along with the ability to customize radiotherapy doses to fit the particular radiosensitivity profile of the tumor.